FDA Recalls Over 233,000 Bottles of Duloxetine Over Cancer Risk The U.S. Food and Drug Administration (FDA) has announced the recall of over 233,000 bottles of duloxetine, a common antidepressant, due to the presence of nitrosamine impurities—chemicals that can increase the risk of cancer when consumed in excessive amounts over extended periods. Initially, the FDA recalled approximately 7,100 bottles of…
